Home » Authors » Cormac Sheridan

Articles by Cormac Sheridan

Modex Plans To Move EPO Cell Therapy Into Phase II

March 21, 2001

By Cormac Sheridan

Pantheco Raises DKK53.7M, Licenses PNA Technology

March 7, 2001

By Cormac Sheridan

Bavarian Nordic Licenses Vaccine Technology From Australian Firm

Feb. 7, 2001

By Cormac Sheridan

Bavarian Nordic Licenses Vaccine Technology From Australian Firm

Feb. 7, 2001

By Cormac Sheridan

Austrian Company Intercell Raises EUR27M For Synthetic Vaccines

Jan. 17, 2001

By Cormac Sheridan

Austrian Company Intercell Raises EUR27M For Synthetic Vaccines

Jan. 17, 2001

By Cormac Sheridan

Combio Spun Off From Carlsberg To Develop Chemistry Platform

Jan. 10, 2001

By Cormac Sheridan

Combio Spun Off From Carlsberg To Develop Chemistry Platform

Jan. 10, 2001

By Cormac Sheridan

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Cosmo data positive for first new hair-loss approach in decades
BioWorld
Shares of Cosmo Pharmaceuticals NV rose sharply on Dec. 3 following top-line pivotal phase III data showing a statistically significant and clinically meaningful...